Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Allogene Therapeutics Inc’s stock clocked out at $1.37, down -3.52% from its previous closing price of $1.42. In other words, the price has decreased by -$3.52 from its previous closing price. On the day, 2.57 million shares were traded. ALLO stock price reached its highest trading level at $1.45 during the session, while it also had its lowest trading level at $1.36.
Ratios:
To gain a deeper understanding of ALLO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.54 and its Current Ratio is at 8.54. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.20.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $11.Piper Sandler initiated its Overweight rating on May 31, 2024, with a $11 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 14 ’25 when Chang David D sold 46,668 shares for $1.96 per share. The transaction valued at 91,469 led to the insider holds 5,276,569 shares of the business.
Beneski Benjamin Machinas sold 5,488 shares of ALLO for $10,839 on Mar 14 ’25. The SVP, Chief Technical Officer now owns 218,507 shares after completing the transaction at $1.98 per share. On Mar 14 ’25, another insider, Beneski Benjamin Machinas, who serves as the Officer of the company, bought 5,488 shares for $1.97 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 307393760 and an Enterprise Value of 111141224. For the stock, the TTM Price-to-Sale (P/S) ratio is 14882.83 while its Price-to-Book (P/B) ratio in mrq is 0.69. Its current Enterprise Value per Revenue stands at 5051.874 whereas that against EBITDA is -0.456.
Stock Price History:
The Beta on a monthly basis for ALLO is 0.62, which has changed by -0.6394737 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, ALLO has reached a high of $4.25, while it has fallen to a 52-week low of $1.23. The 50-Day Moving Average of the stock is -22.48%, while the 200-Day Moving Average is calculated to be -40.73%.
Shares Statistics:
It appears that ALLO traded 5.49M shares on average per day over the past three months and 3356030 shares per day over the past ten days. A total of 212.21M shares are outstanding, with a floating share count of 139.53M. Insiders hold about 35.78% of the company’s shares, while institutions hold 63.35% stake in the company. Shares short for ALLO as of 1741910400 were 38012142 with a Short Ratio of 6.33, compared to 1739491200 on 33662897. Therefore, it implies a Short% of Shares Outstanding of 38012142 and a Short% of Float of 24.260001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
